Sign in

CIK 0001962011 · <br>Emerging growth company

Kairos Pharma, LTD.

Sign in to watch
Ticker
KAPA
Exchange
NYSE
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
operating
EIN
462993314
Phone
818-404-5541
Business address
2355 WESTWOOD BLVD. #139, LOS ANGELES, CA, 90064
  1. 10-Q Report Quarterly Report
  2. 10-K/A Report 10-K/A
  3. 8-K Event Other events
  4. 8-K Event Material agreement · Shareholder vote results
  5. 8-K Event Other events
  6. DEFR14A Other DEFR14A
  7. SCHEDULE 13G Stake Statement of Beneficial Ownership
  8. 10-Q Report Quarterly Report
  9. PRER14A Other PRER14A
  10. DEF 14A Proxy Proxy Statement
  11. 3 Insider Initial Statement of Ownership
  12. 10-K/A Report 10-K/A
  13. 8-K Event Auditor change
  14. 424B3 Offering Prospectus
  15. EFFECT Other Notice of Effectiveness
  16. 8-K Event Other events
  17. CORRESP Other Correspondence Between Filers and SEC Staff
  18. S-1 Offering Registration Statement
  19. 10-K Report Annual Report
  20. 4 Insider Changes in Ownership

Page 3 of 7 · 125 filings